Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

11.01.2023 / 11:06 CET/CEST
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Christof
Last name(s): Dreibholz

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Dermapharm Holding SE

b) LEI
5299009F0KNZINQQQK37 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A2GS5D8

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
38.1000 EUR 7620.00 EUR
38.1000 EUR 7620.00 EUR
38.2200 EUR 34398.00 EUR

d) Aggregated information
Price Aggregated volume
38.1831 EUR 49638.0000 EUR

e) Date of the transaction
10/01/2023; UTC+1

f) Place of the transaction
Name: Tradegate Exchange
MIC: TGAT



11.01.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service

80395  11.01.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1532699&application_name=news&site_id=zonebourse_sftp